March 19, 2024 The Best Source of News, Culture, Lifestyle for Culver City, Mar Vista, Del Rey, Palms and West Los Angeles

Cedars-Sinai Develops New Gene Therapy to Combat Lou Gehrig’s Disease

Cedars-Sinai announced Thursday its regenerative medicine investigators have received approval from the U.S. Food and Drug Administration to test a combination stem cell-gene therapy they developed to stall the progression of Lou Gehrig’s disease.

The approval allows patients to receive a new investigational drug in a few months when the study begins at the Cedar-Sinai Board of Governors Regenerative Medicine Institute.

This will be the first clinical trial to test the safety of this type of therapy, developed with the intention of preserving leg mobility in patients with Lou Gehrig’s disease, also called amyotrophic lateral sclerosis, which attacks motor neurons, cells that control muscles.

Enrollment could begin by the end of this year.

There is no effective treatment for the disease, only medications to alleviate symptoms, such as muscle spasms, or mechanical devices to help patients breathe. As a result, this clinical trial is seen by many as significant.

“Any time you’re trying to treat an incurable disease, it is a long shot, but we believe the rationale behind our new approach is strong,” said Clive Svendsen, director of the Cedars-Sinai Board of Governors Regenerative Medicine Institute, who has spent a dozen years developing the new approach.

The new approach, funded by the California Institute for Regenerative Medicine and outlined in a 4,600-page application to the FDA, involves engineering stem cells to produce an important protein — glial cell line derived neurotrophic factor. The stem cells producing GDNF then can protect the motor neurons that allow impulses to pass from the brain or spinal cord to a muscle.

When a healthy person wants to move a leg, for example, the brain sends a signal along that pathway to the motor neuron that enables the movement. Patients with ALS develop progressive paralysis as the disease causes motor neurons to die.

Motor neurons that die in ALS don’t exist in a vacuum — they have support cells called glia that enable the motor neurons to live and operate,” said Svendsen, the Kerry and Simone Vickar Family Foundation Distinguished Chair in Regenerative Medicine.

“What we and others have found in ALS is that the support cells become sick and lack certain proteins that keep motor neurons alive. When the support cells die, the motor neurons also die, causing paralysis that gets worse and worse until the patient can no longer move.”

Svendsen and his team reasoned that if they could keep motor neurons alive by providing the supporting glial cells that make the necessary protein, then perhaps they could improve leg mobility.

Their theory spurred the team to develop this combined stem cell and gene therapy approach. The stem cells engineered to produce GDNF are replicated until billions of cells are formed.

When the protein-enhanced stem cells are infused into the patient’s spinal cord, they generate glial support cells that produce GDNF. The hope is that these support cells will, in turn, keep the motor neurons alive.

“This is a highly innovative approach to a disease that has mystified medicine for generations,” said Dr. Shlomo Melmed, Cedars-Sinai executive vice president for Academic Affairs, dean of the medical faculty and the Helene A. and Philip E. Hixon Distinguished Chair in Investigative Medicine.

The combination of cutting-edge stem cell science, developing a new device to inject the cells, our outstanding research laboratories and the direct involvement of neuroscientists, neurosurgeons and neurologists made this CIRM-funded project possible.”

The stem cell implantations for ALS patients involved in the clinical trial could begin by the end of the year, Svendsen said.

Participants will come from the ALS Clinic at Cedars-Sinai, and the trial will be led by Dr. Robert Baloh and Peggy Allred. The neurosurgical team will be led by Dr. J. Patrick Johnson.

Patients eligible to be considered for the trial must be experiencing ALS-caused weakness in their legs. Cell implantations will take place during a five-hour surgical procedure in which a neurosurgeon will remove a piece of bone in the lumbar region of the patient’s lower back.

Using an investigational device developed specifically for this trial, the surgeon will inject the stem cells directly into the patient’s spinal cord in a section that governs movement on only one side of the body.

Neither the patients nor the physicians caring for the patients will know which side has received the stem cells.

“We will follow the patients for a year and measure the strength in each leg,” Svendsen said.

“In ALS, usually the legs lose strength at the same time. This is a small safety trial to ensure the cells releasing GDNF do not have any negative effects on leg function. If safe, we plan a larger future trial to see if this therapy can improve strength in the treated leg.”

Patients seeking information about potentially participating in the clinical trial should call (310) 423-1791.

The research leading to the clinical trial has been funded by a $16.8 million grant from the California Institute for Regenerative Medicine.

 

Cedars-Sinai

Related Posts

Woman Sentenced for $3.9 Million Fraud and Body Disposal Scheme with Elderly Victim

March 18, 2024

March 18, 2024

Gruesome Attempt to Dispose of Victim’s Body in West Los Angeles Apartment A San Fernando Valley woman has been sentenced...

Roadway Construction Alert at LAX: Plan Your Travel Accordingly

March 18, 2024

March 18, 2024

Lane Restrictions Scheduled Nightly from March 17 to March 23 After this weekend’s closures of Century Boulevard, which frustrated travelers...

Firearms Found After Police Pursuit Ends in West Los Angeles Neighborhood

March 18, 2024

March 18, 2024

Suspect Arrested Following Unintentional Discharge Incident A vehicle pursuit involving officers from the West Los Angeles Division on March 15,...

Tensley Wines to Take Part in Wine Masterclass in Culver City

March 17, 2024

March 17, 2024

Join Joey Tensley for an Exclusive Tasting Experience  Tensley Wines will participate in an exclusive Masterclass hosted by Total Wine...

Culver City Council Approves Monument Signs, Affordable Housing Initiatives

March 17, 2024

March 17, 2024

City leaders greenlight static signs for Culver Steps The Culver City Council has greenlit two static monument signs aimed at...

FBI Seeks Victims of Alleged Online Exploitation Scheme Allegedly Run by Resident of Santa Monica

March 17, 2024

March 17, 2024

Individuals Urged to Come Forward in Investigation of John Douglas Burch The FBI’s Philadelphia Field Office is urging individuals to...

(Video) Sarah Kate Ellis, President and CEO of GLAAD Responds to News of Nex Benedict’s Cause of Death

March 15, 2024

March 15, 2024

Sarah Kate Ellis, President and CEO of GLAAD, responds to the release of the Oklahoma Medical Examiner’s Ruling on Nex...

The Auld Fella: Brentwood and Culver City’s St. Patrick’s Weekend Destination

March 15, 2024

March 15, 2024

Join the Craic at The Auld Fella’s Celebrations: Dining, Drinking, Shenanigans If you are looking for an epic St. Patrick’s...

Venice Family Clinic Announces Inaugural HEART Gala to Celebrate Health and Art

March 15, 2024

March 15, 2024

Event Honors Creative Community and Supporters of Vital Health Care Services Venice Family Clinic, a non-profit community health center dedicated...

“Love Lies Bleeding” is Ripped: Actress Katy O’Brian Talks Love, Sex, and Vulnerability

March 15, 2024

March 15, 2024

Katy O’Brian is a Breakout Star Who Shines in Loving and Hilariously Violent Crime Film English film director Rose Glass’...

IRS Launches Direct File Pilot of Free Filing Tool for Taxpayers in California, 11 Other States

March 14, 2024

March 14, 2024

Free, Convenient Online Tax Filing Option Now Available for Eligible Individuals The Internal Revenue Service (IRS) announced the official launch...

Culver City Police Crack Down on DUIs During Weekend Spree

March 13, 2024

March 13, 2024

Multiple Arrests Made Following Alcohol-Related Incidents Culver City Police reported multiple DUI arrests last weekend following incidents involving drivers suspected...

MICHELIN Guide Unveils 10 New Culinary Stars in California, Anticipating 2024 Selections

March 13, 2024

March 13, 2024

9 Los Angeles Area and Beverly Hills Restaurants Featured as New Additions The prestigious MICHELIN Guide has announced the addition...

Chef Roy Choi Brings Tacos Por Vida to LA With Soft Opening in Palms

March 13, 2024

March 13, 2024

The Lines Are Already Growing at This Newest Roy Choi Taco Stand Celebrated chef Roy Choi is celebrating the debut...

Countdown to the 2024 Los Angeles Marathon: Road Closures Ahead

March 12, 2024

March 12, 2024

Annual Marathon Comes with Saint Patrick’s Day Twist in 2024 Just three days from now, the 2024 Los Angeles Marathon...